| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alectinib superior to chemotherapy in advanced ALK + NSCLC
|
Gourd, Elizabeth
|
|
2018
|
19 |
6 |
p. e285
|
artikel
|
| 2 |
American Association for Cancer Research Annual Meeting 2018
|
del Pozo Martín, Yaiza
|
|
2018
|
19 |
6 |
p. 730-731
|
artikel
|
| 3 |
A new strategy to reduce US drug prices
|
Burki, Talha Khan
|
|
2018
|
19 |
6 |
p. 732
|
artikel
|
| 4 |
Antineoplastons: when is enough enough?
|
Figg, William D
|
|
2018
|
19 |
6 |
p. 733-734
|
artikel
|
| 5 |
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
|
Pernas, Sonia
|
|
2018
|
19 |
6 |
p. 812-824
|
artikel
|
| 6 |
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
|
Conforti, Fabio
|
|
2018
|
19 |
6 |
p. 737-746
|
artikel
|
| 7 |
Carboxyamidotriazole orotate in glioblastoma
|
Das, Manjulika
|
|
2018
|
19 |
6 |
p. e292
|
artikel
|
| 8 |
Carcinogenicity of quinoline, styrene, and styrene-7,8-oxide
|
|
|
2018
|
19 |
6 |
p. 728-729
|
artikel
|
| 9 |
Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases
|
Jespersen, Henrik
|
|
2018
|
19 |
6 |
p. e327
|
artikel
|
| 10 |
Chemoradiotherapy for pancreatic adenocarcinoma
|
Stirrups, Robert
|
|
2018
|
19 |
6 |
p. e293
|
artikel
|
| 11 |
Chronic myeloid leukaemia: going off piste
|
Ross, David M
|
|
2018
|
19 |
6 |
p. 717-718
|
artikel
|
| 12 |
Correction to Lancet Oncol 2018; 19: 728–29
|
|
|
2018
|
19 |
6 |
p. e283
|
artikel
|
| 13 |
Correction to Lancet Oncol 2018; 19: 549–61
|
|
|
2018
|
19 |
6 |
p. e283
|
artikel
|
| 14 |
Correction to Lancet Oncol 2018; 19: e102–12
|
|
|
2018
|
19 |
6 |
p. e283
|
artikel
|
| 15 |
Cystic fibrosis: a gastrointestinal cancer syndrome
|
Slae, Mordechai
|
|
2018
|
19 |
6 |
p. 719-720
|
artikel
|
| 16 |
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
|
Saussele, Susanne
|
|
2018
|
19 |
6 |
p. 747-757
|
artikel
|
| 17 |
Does a patient's sex predict the efficacy of cancer immunotherapy?
|
Abdel-Rahman, Omar
|
|
2018
|
19 |
6 |
p. 716-717
|
artikel
|
| 18 |
Don't let the data cloud the image
|
Ranscombe, Peter
|
|
2018
|
19 |
6 |
p. 736
|
artikel
|
| 19 |
Elderly patients with metastatic renal cell carcinoma: position paper from the International Society of Geriatric Oncology
|
Kanesvaran, Ravindran
|
|
2018
|
19 |
6 |
p. e317-e326
|
artikel
|
| 20 |
Exercise and cancer treatment: balancing patient needs
|
The Lancet Oncology,
|
|
2018
|
19 |
6 |
p. 715
|
artikel
|
| 21 |
Flexible sigmoidoscopy screening for colorectal cancer
|
Burki, Talha Khan
|
|
2018
|
19 |
6 |
p. e291
|
artikel
|
| 22 |
Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer
|
Soto-Perez-de-Celis, Enrique
|
|
2018
|
19 |
6 |
p. e305-e316
|
artikel
|
| 23 |
Genetic predisposition to medulloblastomas: just follow the tumour genome
|
Bourdeaut, Franck
|
|
2018
|
19 |
6 |
p. 722-723
|
artikel
|
| 24 |
Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging
|
Biragyn, Arya
|
|
2018
|
19 |
6 |
p. e295-e304
|
artikel
|
| 25 |
Improving the health of Indigenous people globally
|
Ghebreyesus, Tedros Adhanom
|
|
2018
|
19 |
6 |
p. e277
|
artikel
|
| 26 |
Improving the health of Indigenous people globally
|
Sarfati, Diana
|
|
2018
|
19 |
6 |
p. e276
|
artikel
|
| 27 |
Late infection-related mortality in asplenic cancer survivors
|
Gourd, Elizabeth
|
|
2018
|
19 |
6 |
p. e288
|
artikel
|
| 28 |
Low uptake of tamoxifen to prevent breast cancer
|
Gourd, Elizabeth
|
|
2018
|
19 |
6 |
p. e290
|
artikel
|
| 29 |
[177Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet?
|
Paganelli, Giovanni
|
|
2018
|
19 |
6 |
p. 725-726
|
artikel
|
| 30 |
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
|
Hofman, Michael S
|
|
2018
|
19 |
6 |
p. 825-833
|
artikel
|
| 31 |
Medulloblastoma in infants: the never-ending challenge
|
Lassaletta, Alvaro
|
|
2018
|
19 |
6 |
p. 720-721
|
artikel
|
| 32 |
New treatment option for Waldenström macroglobulinaemia
|
Das, Manjulika
|
|
2018
|
19 |
6 |
p. e287
|
artikel
|
| 33 |
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial
|
Gregorc, Vanesa
|
|
2018
|
19 |
6 |
p. 799-811
|
artikel
|
| 34 |
Novel gene variant for melanoma predisposition
|
Das, Manjulika
|
|
2018
|
19 |
6 |
p. e284
|
artikel
|
| 35 |
One pair of shorts
|
Ross, Jeremy A
|
|
2018
|
19 |
6 |
p. 735
|
artikel
|
| 36 |
Outcomes after autoBMT in cancer survivors
|
Gunjur, Ashray
|
|
2018
|
19 |
6 |
p. e286
|
artikel
|
| 37 |
Predictive gene-expression score for follicular lymphoma
|
Adams, Hugo J A
|
|
2018
|
19 |
6 |
p. e280
|
artikel
|
| 38 |
Predictive gene-expression score for follicular lymphoma
|
Sorigue, Marc
|
|
2018
|
19 |
6 |
p. e279
|
artikel
|
| 39 |
Predictive gene-expression score for follicular lymphoma
|
Tanimoto, Tetsuya
|
|
2018
|
19 |
6 |
p. e281
|
artikel
|
| 40 |
Predictive gene-expression score for follicular lymphoma – Authors' reply
|
Huet, Sarah
|
|
2018
|
19 |
6 |
p. e282
|
artikel
|
| 41 |
Predictive gene-expression score for follicular lymphona
|
Gao, Qiang
|
|
2018
|
19 |
6 |
p. e278
|
artikel
|
| 42 |
Quality of life after multicatheter breast brachytherapy
|
Jagsi, Reshma
|
|
2018
|
19 |
6 |
p. 726-727
|
artikel
|
| 43 |
Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial
|
Schäfer, Rebekka
|
|
2018
|
19 |
6 |
p. 834-844
|
artikel
|
| 44 |
Reduced-dose dasatinib in chronic-phase CML
|
Das, Manjulika
|
|
2018
|
19 |
6 |
p. e294
|
artikel
|
| 45 |
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
|
Robinson, Giles W
|
|
2018
|
19 |
6 |
p. 768-784
|
artikel
|
| 46 |
Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis
|
Yamada, Akihiro
|
|
2018
|
19 |
6 |
p. 758-767
|
artikel
|
| 47 |
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
|
Waszak, Sebastian M
|
|
2018
|
19 |
6 |
p. 785-798
|
artikel
|
| 48 |
Targeting the tumour vasculature in mesothelioma
|
Fennell, Dean A
|
|
2018
|
19 |
6 |
p. 723-724
|
artikel
|
| 49 |
UK to align with EU clinical trial rules post-Brexit
|
Burki, Talha Khan
|
|
2018
|
19 |
6 |
p. e289
|
artikel
|
Tijdschrift beschrijving